Invesco Biotechnology & Genome ETF (PBE) is an ETF managed by Invesco. Its largest position is APPLIED MATERIALS INC /DE (AMAT), representing 10.92% of fund assets.
Invesco Biotechnology & Genome ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- PBE
- Type:
- ETF
- Manager:
- Invesco
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 26, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
APPLIED MATERIALS INC /DE
|
10.92% | $27,004,624.19 | 27,001,924 |
|
-
UNITED THERAPEUTICS Corp
|
6.28% | $15,547,576.20 | 27,212 |
|
-
ILLUMINA, INC.
|
5.37% | $13,286,407.68 | 104,832 |
|
-
BIOGEN INC.
|
5.05% | $12,497,212.00 | 66,025 |
|
-
INCYTE CORP
|
4.91% | $12,146,829.73 | 127,499 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
4.84% | $11,979,119.94 | 38,706 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
4.77% | $11,796,589.04 | 16,684 |
|
-
AMGEN INC
|
4.71% | $11,651,658.75 | 33,651 |
|
-
GILEAD SCIENCES, INC.
|
4.62% | $11,417,621.76 | 87,264 |
|
-
APPLIED MATERIALS INC /DE
|
4.20% | $10,392,972.42 | 10,392,972 |
|
-
BIOCRYST PHARMACEUTICALS INC
|
3.42% | $8,458,875.28 | 923,458 |
|
-
CATALYST PHARMACEUTICALS INC
|
3.30% | $8,172,130.69 | 290,513 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
3.28% | $8,110,281.52 | 110,374 |
|
-
Protagonist Therapeutics, Inc
|
3.22% | $7,958,672.55 | 80,415 |
|
-
TG THERAPEUTICS, INC.
|
3.15% | $7,780,716.30 | 230,335 |
|
-
Royalty Pharma plc
|
3.13% | $7,753,481.19 | 154,791 |
|
-
CareDx, Inc.
|
3.07% | $7,597,002.65 | 365,065 |
|
-
NEUROCRINE BIOSCIENCES INC
|
2.86% | $7,065,412.20 | 53,660 |
|
-
EXELIXIS, INC.
|
2.80% | $6,921,621.72 | 155,682 |
|
-
BIO-TECHNE Corp
|
2.73% | $6,749,261.28 | 122,004 |
|
-
PTC THERAPEUTICS, INC.
|
2.68% | $6,628,117.62 | 101,877 |
|
-
VERACYTE, INC.
|
2.62% | $6,482,046.76 | 196,903 |
|
-
ACADIA PHARMACEUTICALS INC
|
2.59% | $6,415,918.15 | 285,787 |
|
-
Vericel Corp
|
2.58% | $6,380,803.98 | 183,726 |
|
-
HALOZYME THERAPEUTICS, INC.
|
2.57% | $6,358,360.80 | 99,880 |
|
-
REPLIGEN CORP
|
2.50% | $6,173,770.73 | 52,183 |
|
-
Theravance Biopharma, Inc.
|
2.49% | $6,172,104.96 | 368,704 |
|
-
IONIS PHARMACEUTICALS INC
|
2.49% | $6,148,262.40 | 82,240 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
2.45% | $6,050,049.75 | 112,225 |
|
-
COLLEGIUM PHARMACEUTICAL, INC
|
2.12% | $5,247,645.94 | 155,578 |
|
-
QIAGEN N.V.
|
2.03% | $5,010,585.93 | 144,898 |
|
-
MANNKIND CORP
|
1.45% | $3,589,866.32 | 1,268,504 |
|
-
INVESCO GOVERNMENT & AGENCY PORTFOLIO
|
0.06% | $146,277.13 | 146,277 |
Advertisement (320x50)